Skip to main content

Laura Barlow Enyedi

Professor of Ophthalmology
Ophthalmology
Box 3802 Med Ctr, Durham, NC
Dept of Ophthalmology, Durham, NC

Selected Grants


Randomized Trial of Full-Time Occlusion Therapy for Intermittent Exotropia in Children

ResearchPrincipal Investigator · Awarded by Jaeb Center For Health Research · 2022 - 2028

A Randomized Trial to Evaluate Sequential vs Simultaneous Spectacles plus Patching for Amblyopia in Children 3 to <13 Years Old (ATS22)

ResearchPrincipal Investigator · Awarded by Jaeb Center For Health Research · 2021 - 2028

Intermittent Exotropia Study (IXT6) A Pilot Randomized Clinical Trial of Base-in Prism Spectacles for Intermittent Exotropia

ResearchPrincipal Investigator · Awarded by Jaeb Center For Health Research · 2019 - 2024

An RCT of Overminus Spectacle Therapy for Intermittent Exotropia

ResearchPrincipal Investigator · Awarded by Jaeb Center For Health Research · 2018 - 2023

Two-Year Follow Up after Treatment of Severe Retinopathy of Prematurity with Low-Dose Bevacizumab (ROP2Y)

ResearchPrincipal Investigator · Awarded by Jaeb Center For Health Research · 2018 - 2023

Binocular Dig Rush Game Treatment for Amblyopia (ATS20)

ResearchPrincipal Investigator · Awarded by Jaeb Center For Health Research · 2017 - 2022

Pediatric Optic Neuritis Prospective Outcomes Study (PON1)

ResearchPrincipal Investigator · Awarded by Jaeb Center For Health Research · 2016 - 2022

Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity (ROP1)

ResearchPrincipal Investigator · Awarded by Jaeb Center For Health Research · 2015 - 2022

Pediatric Cataract Surgery Outcomes Registry (CO2)

ResearchPrincipal Investigator · Awarded by Jaeb Center For Health Research · 2013 - 2022

A Prospective Observational Study of Adult Strabismus

ResearchPrincipal Investigator · Awarded by Jaeb Center For Health Research · 2015 - 2018

External Relationships


  • Leadiant biosciences
  • Wolters Kluwer Health (publishing)

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.